BR9710467A - M-todo para tratamento e preven-Æo de distÚrbios neurodegenerativos atrav-s de administra-Æo de uma tiazolidinona - Google Patents
M-todo para tratamento e preven-Æo de distÚrbios neurodegenerativos atrav-s de administra-Æo de uma tiazolidinonaInfo
- Publication number
- BR9710467A BR9710467A BR9710467A BR9710467A BR9710467A BR 9710467 A BR9710467 A BR 9710467A BR 9710467 A BR9710467 A BR 9710467A BR 9710467 A BR9710467 A BR 9710467A BR 9710467 A BR9710467 A BR 9710467A
- Authority
- BR
- Brazil
- Prior art keywords
- pct
- thiazolidinone
- administration
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2157196P | 1996-07-11 | 1996-07-11 | |
| PCT/US1997/011586 WO1998002160A1 (en) | 1996-07-11 | 1997-07-01 | Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9710467A true BR9710467A (pt) | 1999-08-17 |
Family
ID=21804973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9710467A BR9710467A (pt) | 1996-07-11 | 1997-07-01 | M-todo para tratamento e preven-Æo de distÚrbios neurodegenerativos atrav-s de administra-Æo de uma tiazolidinona |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5912259A (pt) |
| EP (1) | EP0914122B1 (pt) |
| JP (1) | JP2001508028A (pt) |
| KR (1) | KR20000023683A (pt) |
| CN (1) | CN1145481C (pt) |
| AT (1) | ATE250416T1 (pt) |
| AU (1) | AU726664B2 (pt) |
| BR (1) | BR9710467A (pt) |
| CA (1) | CA2255073A1 (pt) |
| CO (1) | CO4940509A1 (pt) |
| DE (1) | DE69725147T2 (pt) |
| DK (1) | DK0914122T3 (pt) |
| ES (1) | ES2205247T3 (pt) |
| HK (1) | HK1020533A1 (pt) |
| HR (1) | HRP970362A2 (pt) |
| IL (1) | IL127487A (pt) |
| NO (1) | NO990076D0 (pt) |
| NZ (1) | NZ332763A (pt) |
| PL (1) | PL331049A1 (pt) |
| PT (1) | PT914122E (pt) |
| TR (1) | TR199900040T2 (pt) |
| WO (1) | WO1998002160A1 (pt) |
| ZA (1) | ZA976142B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003104423A2 (en) * | 2002-06-11 | 2003-12-18 | Roy Ogle | Meningeal-derived stem cells |
| US20110104296A1 (en) * | 2008-05-08 | 2011-05-05 | Dipak Kumar Sarkar | Endorphin Therapy Compositions and Methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT83152B (pt) * | 1985-08-09 | 1989-03-30 | Lilly Co Eli | Processo para a preparacao de compostos di-t-butilfenoicos |
| EP0391644B1 (en) * | 1989-04-07 | 1996-06-19 | Eli Lilly And Company | Aryl-substituted rhodanine derivatives |
| US5143928A (en) * | 1990-03-27 | 1992-09-01 | Warner-Lambert Company | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
| US5192753A (en) * | 1991-04-23 | 1993-03-09 | Mcgeer Patrick L | Anti-rheumatoid arthritic drugs in the treatment of dementia |
| ZA936492B (en) * | 1992-09-10 | 1995-03-02 | Lilly Co Eli | Compounds useful as hypoglycemic agents and for treating Alzheimer's disease. |
| WO1996022772A1 (en) * | 1995-01-23 | 1996-08-01 | Eli Lilly And Company | Method for treating multiple sclerosis |
| ATE301457T1 (de) * | 1995-06-12 | 2005-08-15 | Searle & Co | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
-
1997
- 1997-07-01 EP EP97933264A patent/EP0914122B1/en not_active Expired - Lifetime
- 1997-07-01 TR TR1999/00040T patent/TR199900040T2/xx unknown
- 1997-07-01 DE DE69725147T patent/DE69725147T2/de not_active Expired - Fee Related
- 1997-07-01 AT AT97933264T patent/ATE250416T1/de not_active IP Right Cessation
- 1997-07-01 WO PCT/US1997/011586 patent/WO1998002160A1/en active IP Right Grant
- 1997-07-01 JP JP50606698A patent/JP2001508028A/ja not_active Ceased
- 1997-07-01 AU AU36491/97A patent/AU726664B2/en not_active Ceased
- 1997-07-01 BR BR9710467A patent/BR9710467A/pt not_active Application Discontinuation
- 1997-07-01 IL IL12748797A patent/IL127487A/en not_active IP Right Cessation
- 1997-07-01 CA CA002255073A patent/CA2255073A1/en not_active Abandoned
- 1997-07-01 ES ES97933264T patent/ES2205247T3/es not_active Expired - Lifetime
- 1997-07-01 US US09/171,891 patent/US5912259A/en not_active Expired - Fee Related
- 1997-07-01 PL PL97331049A patent/PL331049A1/xx unknown
- 1997-07-01 NZ NZ332763A patent/NZ332763A/xx unknown
- 1997-07-01 CN CNB971960429A patent/CN1145481C/zh not_active Expired - Fee Related
- 1997-07-01 DK DK97933264T patent/DK0914122T3/da active
- 1997-07-01 PT PT97933264T patent/PT914122E/pt unknown
- 1997-07-03 HR HR60/021,571A patent/HRP970362A2/xx not_active Application Discontinuation
- 1997-07-10 ZA ZA9706142A patent/ZA976142B/xx unknown
- 1997-07-10 CO CO97038493A patent/CO4940509A1/es unknown
-
1999
- 1999-01-08 NO NO990076A patent/NO990076D0/no not_active Application Discontinuation
- 1999-01-09 KR KR1019997000140A patent/KR20000023683A/ko active IP Right Grant
- 1999-11-30 HK HK99105554A patent/HK1020533A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO4940509A1 (es) | 2000-07-24 |
| PL331049A1 (en) | 1999-06-21 |
| CN1223582A (zh) | 1999-07-21 |
| KR20000023683A (ko) | 2000-04-25 |
| DE69725147T2 (de) | 2004-07-22 |
| EP0914122A1 (en) | 1999-05-12 |
| PT914122E (pt) | 2003-12-31 |
| NO990076L (no) | 1999-01-08 |
| DE69725147D1 (de) | 2003-10-30 |
| DK0914122T3 (da) | 2003-12-22 |
| EP0914122B1 (en) | 2003-09-24 |
| IL127487A0 (en) | 1999-10-28 |
| NO990076D0 (no) | 1999-01-08 |
| CN1145481C (zh) | 2004-04-14 |
| US5912259A (en) | 1999-06-15 |
| HRP970362A2 (en) | 1998-04-30 |
| ATE250416T1 (de) | 2003-10-15 |
| NZ332763A (en) | 2000-07-28 |
| ZA976142B (en) | 1998-02-02 |
| AU3649197A (en) | 1998-02-09 |
| ES2205247T3 (es) | 2004-05-01 |
| TR199900040T2 (xx) | 1999-04-21 |
| AU726664B2 (en) | 2000-11-16 |
| CA2255073A1 (en) | 1998-01-22 |
| HK1020533A1 (en) | 2000-05-12 |
| JP2001508028A (ja) | 2001-06-19 |
| IL127487A (en) | 2002-04-21 |
| WO1998002160A1 (en) | 1998-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69709070T2 (de) | Verbrückte zyklische aminosäuren als pharmazeutische mittel | |
| IL128416A0 (en) | Pharmaceutical composition for the treatment of alzheimer's disease | |
| HRP970560B1 (en) | Substituted gamma aminobutyric acids as pharmaceutical agents | |
| BG104686A (en) | Glycine transport inhibitors | |
| DK0888325T3 (da) | Cykliske aminosyrer som farmaceutiske midler | |
| IS1990B (is) | Nýstárlegar staðgengnar hringamínósýrur notaðar til lyfjagerðar | |
| PT95117A (pt) | Metodo para o tratamento da ejaculacao precoce utilizando sertralina | |
| EP0744176A3 (en) | Methods for inhibiting bone loss | |
| BR9710467A (pt) | M-todo para tratamento e preven-Æo de distÚrbios neurodegenerativos atrav-s de administra-Æo de uma tiazolidinona | |
| PT858337E (pt) | Composicao farmaceutica para o tratamento de doencas auto-imunes | |
| NO955313D0 (no) | Anvendelse av ropivacain i fremstillingen av et farmasöytikum med analgetisk effekt som har minimal motorisk blokkering | |
| EP1447090B8 (de) | Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen | |
| FI953622A0 (fi) | Ifenprodiilin ja sen diastereoisomeerien käyttö lääkeaineiden valmistukseen, jotka lääkeaineet ovat käyttökelpoisia perifeeristen neuropatiatilojen ja keskushermoston degeneratiivisten sairauksien hoitoon | |
| FR2818147B1 (fr) | Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine | |
| HUP9903936A2 (hu) | Tiazolidinonszármazék alkalmazása neurodegenerációs rendellenességek kezelésére és megelőzésére szolgáló gyógyszerkészítmények előállítására | |
| SE9501773D0 (sv) | New use | |
| FR2752163B1 (fr) | Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington | |
| RU95116290A (ru) | Применение 5-морфолино-3-(4-хлорбензилиденамин)-2-оксазолидинона, фармацевтическая композиция на его основе, способ лечения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |